LEA vs TMO · P/E 14, rev $23.31B vs P/E 24, rev $44.56B
Lear Corporation (LEA) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Lear Corporation (LEA) is a auto parts company listed on US.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported LEA revenue for 2024-12-31 was $23.31B. Net income was $591.8M. Revenue was down 0.7% from 2023-12-31 to 2024-12-31. LEA currently screens at market cap $7.21B and trailing P/E 14.4.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
LEA currently screens at market cap $7.21B and trailing P/E 14.4. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the LEA and TMO stock pages for the full models.
Not investment advice.